Since 2001, the International Myeloma Working Group’s achievements have changed the landscape of myeloma research. This collaborative effort has brought about breakthroughs in treatment options and diagnostic systems that prolong lives. The IMWG consists of nearly 200 leading myeloma researchers from around the world who collaborate on a broad range of myeloma research projects. Their work focuses on protocols to provide a more durable remission for myeloma patients while improving quality of life, and addressing the needs of both myeloma patients and the physicians who treat them.

IMWG Publications

  • International Myeloma Working Group (IMWG) Criteria for the Diagnosis of Multiple Myeloma

    The updated criteria for the diagnosis of myeloma represent a paradigm shift in the approach to myeloma and have considerable impact on the management of the disease. For decades the diagnosis of

  • Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    The clinical outcome of multiple myeloma (MM) is heterogeneous. A simple and reliable tool is needed to stratify patients with MM. We combined the International Staging System (ISS) with chromosomal

  • Geriatric assessment predicts survival and toxicities in elderly myeloma: an International Myeloma Working Group report

    The IMF’s research arm, the International Myeloma Working Group (IMWG), published an important new study on the assessment of elderly myeloma patients in the journal Blood. In the paper, the IMWG